Investment portfolio.
We provide smart capital for Belgian innovation and driving socio-economic growth.
Our role is to create
sustainable long-term value.
all our investments are driven by our values.
BELGIAN GROWTH FUND I
Détention du capital49 %
Created in April 2019, the Belgian Growth Fund is a fund of funds inspired by a similar successful model in Denmark, supporting funds that invest in Belgian and international companies with promising prospects and help them grow.
BELGIAN INFRASTRUCTURE FUND - I4B
Détention du capital33.33 %
I4B was established in February 2019 to support the development of Belgian infrastructure and facilities. It has three entities in its capital: SFPIM, AG Insurance and Synatom. The fund covers a variety of sectors, such as the energy transition, transport, social infrastructure and telecommunication infrastructure.
BELGIAN MOBILE ID (ITSME)
Détention du capital20 %
Digital identity for secure online identification
BELIGHTNING SRL
Détention du capital48.53 %
Company specialized in aeronautical and space construction.
Belgian Growth Fund
Détention du capital49.00 %
Created in April 2019, the Belgian Growth Fund is a fund of funds inspired by a similar successful model in Denmark, supporting funds that invest in Belgian and international companies with promising prospects and help them grow.
BILOBA (Ginkgo Fund I)
Détention du capital24.27 %
The purpose of the Luxembourg company is to acquire shares of the Ginkgo Fund. The Ginkgo Fund invests in brownfield redevelopment projects in France and Belgium.
BIOCARTIS GROUP
Détention du capital7.28 %
Specialized group in the development of molecular diagnostic systems.
BIODISCOVERY 5
Détention du capital1.63 %
Biodiscovery 5 is the fifth generation of the Biodiscovery fund, which invests in developing therapeutic products and medical/diagnostic devices. The fund is made up of experts in the biosciences sector, with the aim of offering a financial product that provides simple but well thought-out access to the sector. Biodiscovery estimates the risks, time and resources necessary to develop innovative projects up to the crucial phases of value creation.
BIODISCOVERY 6
Détention du capital2.97 %
Life Science - International investment fund
BIOQUBE FACTORY FUND
Détention du capital9.06 %
The Bioqube Factory Fund was set up by three partners (Nico Vandervelpen, Debora Dumont and Dirk Reyn) who started supervising promising R&D projects in 2016 at the Janssen Pharmaceutica site in Beerse. They want to continue to build on the knowledge gained and successes achieved by attracting additional funding, so that they have sufficient financial capacity to focus on the development of the Belgian life sciences ecosystem.
BIOXODES
Détention du capital24.72 %
Bioxodes is a company that, starting from studies at the Brussel’s University on the tick saliva, developped a molecule with anticoagulant properties without risk on bleeding.
